Moderna CEO Eyes European Market to Hit 2028 Breakeven Goals -- Market Talk

Dow Jones
01/14

1113 ET - Moderna is eyeing international markets, especially in Europe, as the company works to hit a breakeven point in 2028, CEO Stéphane Bancel said Monday at the JPMorgan Healthcare Conference. Bancel points out that Pfizer's partnership with the European Union expires at the end of the year, giving Moderna a window to capture a share of the high-volume Covid-19 vaccine market in Europe. If Moderna is able to get European approval for a flu-plus-Covid combo vaccine in 2026, that would also be a positive catalyst for sales growth, he says. The company is also looking to build on partnerships with governments in the United Kingdom, Canada, and Brazil as it looks to drive geographic diversity, Bancel says.(elias.schisgall@wsj.com)

 

(END) Dow Jones Newswires

January 13, 2026 11:13 ET (16:13 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10